“How to” guide for pharmacist‐led implementation of beta‐lactam therapeutic drug monitoring in the critically ill

SE Ausman, LN Moreland‐Head… - Journal of the …, 2023 - Wiley Online Library
Beta‐lactam therapeutic drug monitoring (TDM) can improve precision dosing and clinical
outcomes in critically ill patients, but has not been implemented widely in the United States …

Pharmacist-Managed Therapeutic Drug Monitoring Programs within Australian Hospital and Health Services—A National Survey of Current Practice

P Firman, KS Tan, A Clavarino, MW Taing, K Whitfield - Pharmacy, 2022 - mdpi.com
Pharmacist-managed therapeutic drug monitoring (TDM) services have demonstrated
positive outcomes in the literature, including reduced duration of therapy and decreased …

Why is the implementation of beta-lactam therapeutic drug monitoring for the critically ill falling short? A multicenter mixed-methods study

EF Barreto, PN Chitre, KH Pine… - Therapeutic Drug …, 2023 - journals.lww.com
Background: Beta-lactam therapeutic drug monitoring (BL TDM; drug level testing) can
facilitate improved outcomes in critically ill patients. However, only 10%–20% of hospitals …

Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study

EF Barreto, AD Rule, MH Alshaer, JA Roberts… - Implementation science …, 2021 - Springer
Background Beta-lactams (ie, penicillins, cephalosporins, carbapenems, monobactams) are
the most widely used class of antibiotics in critically ill patients. There is substantial …

[HTML][HTML] Awareness, perception, and barriers of healthcare providers toward the revised consensus guideline for therapeutic monitoring of vancomycin

SS Alghanem, A Albassam, N Al-Rashidi… - Saudi Pharmaceutical …, 2023 - Elsevier
Background A revised consensus guideline published in 2020 recommended transitioning
vancomycin monitoring to the area under the concentration–time curve over 24 h to …

[HTML][HTML] Vancomycin Therapeutic Drug Monitoring: A Cross-Sectional Survey of Canadian Hospitals

SCJ Jorgensen, M McIntyre, J Curran… - The Canadian Journal of …, 2023 - ncbi.nlm.nih.gov
Background Little is known about the current landscape of vancomycin therapeutic drug
monitoring (TDM) in Canadian hospitals, which operate within publicly funded health care …

[HTML][HTML] 최저농도기반반코마이신치료약물농도감시와곡선아래면적기반반코마이신치료약물농도감시비교: 컴퓨터시뮬레이션연구

응준, 현승, 형두, 수연 - Laboratory Medicine, 2022 - synapse.koreamed.org
Lab Med Online Laboratory Medicine Online Lab Med Online 2093-6338 Korean Society for
Laboratory Medicine 10.47429/lmo.2022.12.4.285 lmo-12-4-285 원저 임상화학 Comparison of …

[HTML][HTML] Comparison of Trough-Based and Area Under the Curve-Based Therapeutic Drug Monitoring of Vancomycin: An In Silico Study

E Yoon, HS Lee, HD Park, SY Lee - Laboratory Medicine Online - synapse.koreamed.org
Background Recent American guideline published in 2020 recommend using 24-h area
under the curve (AUC)/minimum inhibitory concentration instead of vancomycin serum …

Pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes

ER Gregory, L Stun, MJ Mason, NM Wilson… - Antimicrobial …, 2022 - cambridge.org
The updated vancomycin guideline for treatment of serious methicillin-resistant
Staphylococcus aureus infections prompted institutions to convert from trough to area-under …

Transitioning From Consult-Based to Automatic Pharmacy-Driven Vancomycin Management: Results From a Single, Primary Care Center

JL Cole, R O'Glee, M Clark… - Journal of Pharmacy …, 2022 - journals.sagepub.com
Objective: The transition to area under the curve (AUC) vancomycin monitoring requires
substantial updates in pharmacy policies and procedures. The study facility was tasked with …